SHS News Current page: 2

The fast-growing Norwegian healthcare provider Dropin enables short-term medical consultation and treatment – in person on site as well as digitally via app Dropin posted revenue of more than 30m EUR in 2021, constituting a CAGR of more than 100% for the last three years SHS invests from its fifth fund generation in the Scandinavian […]

The fast-growing MedTech company phenox specialises in instruments and implants for the neurointerventional therapy of stroke With the growth capital provided by SHS et al., the Bochum-based company has developed from a start-up into a global leader in the field of stroke therapy A successful exit for investors from the third SHS fund generation The […]

c-LEcta was able to translate technology leadership into tremendous commercial growth during the holding period of SHS Leipzig-based c-LEcta’s clients include international corporations in the pharmaceutical, chemical and food industries. With the acquisition, Kerry Group intends to further expand the internationalization of the company in the field of enzymes Tübingen / 15.02.2022 The Tübingen-based growth […]

VAMDRUP, Denmark, February 3rd, 2022 – Impilo and SHS have acquired Lowenco A/S (“Lowenco” or the “Company”) from its founder and owners. Lowenco was founded 2013 in Vamdrup, Denmark, and develops, manufactures, markets, and installs large scale modular and highly energy efficient ultra-low temperature (“ULT”) storage solutions for commercial biopharma, primarily targeting the drug substance […]

Medical technology market in Germany to remain at a high level in 2020, but with slight declines Pandemic leaves both positive and negative traces on medical technology companies SHS expects better development for medical technology than for the overall economy in Germany in 2021 despite Corona The new regulatory requirements (MDR) continue to burden many […]

This funding round allocated in tranches will strengthen PathoQuest’s position as a leading NGS-based biosafety CRO for the biopharmaceutical industry. Paris, FRANCE, Tübingen, GERMANY – November 9th, 2021 – PathoQuest, a pioneer in the quality control of biologics using Next-Generation Sequencing (NGS), today announced the closing of a financing round up to €15M. This funding […]

SHS has been investing according to ethical standards for more than 25 years and its ESG policy is an important aspect of investment decisions. Now it is also becoming a member of the PRI (UN Principles for Responsible Investment) The Tübingen-based healthcare investor has committed itself to contractual compliance with the requirements of the UN […]

Atlas Antibodies acquires evitria Atlas Antibodies has agreed to acquire evitria, a world leader in transient recombinant antibody expression in CHO cells. This transformative acquisition brings together a leading provider of highly validated research antibodies and a front-runner in the field of custom recombinant antibody expression. Since its inception in 2010, evitria has been singularly […]

An interview with Dr Hanno Kühn, Chief Investment Officer (CIO) and head of apoBank’s institutional investment business, and Hubertus Leonhardt, Managing Director and partner of SHS Gesellschaft für Beteiligungsmanagement mbH. Düsseldorf and Tübingen , 22.7.2021 As the largest cooperative primary bank in Germany, apoBank is the number one financial services provider in the health care […]

The Tübingen-based healthcare investor SHS has accompanied Crystal GmbH on its growth path with its know-how, the required capital and extensive networks. Crystal’s optical components are used, for example, in the medical technology industry in respirators and as diffusion-bonded laser crystals in the manufacture of laser systems. The new investor Silver Investment Partners (SIP) will […]

Incision is rapidly expanding its platform for surgical performance and online training The German SHS Gesellschaft für Beteiligungsmanagement mbH and investor Rubio Impact Ventures from Amsterdam provide 5 million euros for the expansion of Incision Group’s international business Operating room staff and surgical residents from over 200 hospitals in more than 18 countries now use […]

In the course of a successful succession arrangement, Tübingen-based SHS Gesellschaft für Beteiligungsmanagement mbH sells its shares in medigroba GmbH to Löwenstein Group With SHS as majority shareholder, medigroba has more than doubled revenue and tripled EBITDA in the last four and a half years Due to the continuing trend towards outpatient care, the medium-sized […]